rss
Br J Ophthalmol 2003;87:173-176 doi:10.1136/bjo.87.2.173
  • Original Article
    • Clinical science

Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation

  1. J A Montero1,
  2. J M Ruiz-Moreno1,2
  1. 1Instituto Oftalmológico de Alicante, Vitreo-Retinal Unit, Alicante, Spain
  2. 2Department of Ophthalmology, Miguel Hernández University School of Medicine, Alicante, Spain
  1. Correspondence to: Javier A Montero, Instituto Oftalmológico de Alicante, Avenida de Denia 111, 03015, Alicante, Spain; msm02va{at}wanadoo.es
  • Accepted 8 September 2002

Abstract

Aims: To analyse the visual and angiographic results of photodynamic therapy (PDT) with verteporfin in highly myopic patients with subfoveal choroidal neovascularisation (CNV).

Methods: PDT was performed on highly myopic patients with subfoveal CNV. The patient population was divided into two groups according to age at onset of CNV (group 1 aged ≤ 55 and group 2 aged >55 years old). Best corrected visual acuity (BCVA) and angiographic findings were considered.

Results: At the end of follow up group 2 had worse BCVA than group 1. 76% of patients in both groups showed a complete closure of CNV at the end of follow up.

Conclusion: Visual prognosis of myopic CNV treated by PDT is influenced by age at onset.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.